Immuron

IMRN · ASX

$0.9535+$0.0042 (+0.44%)TodayMarket closed · Oct 23, 6:44 PM ET

Prev close $0.9493

Latest news

NewsSep 4, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsSep 4, 12:13 PM ETAvi Kapoor
Gold Falls Over 1%; American Outdoor Brands Shares Jump After Q1 Results
NewsSep 4, 10:07 AM ETAvi Kapoor
Dow Falls Over 100 Points; US Economy Adds 162,000 Jobs In August
NewsSep 4, 9:11 AM ETHenry Khederian
Immuron Stock Surges Friday: What's Driving the Action?
NewsSep 4, 7:22 AM ET
Market-Moving News for September 4th
Press releaseJul 6, 6:00 AM ETGlobe Newswire
Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy
NewsMay 27, 5:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsApr 10, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsDec 16, 5:53 AM ETAvi Kapoor
Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
NewsDec 10, 5:00 AM ETAvi Kapoor
Why Braze Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
NewsDec 4, 4:48 AM ETAvi Kapoor
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Press releaseDec 3, 6:00 AM ETGlobe Newswire
Immuron New U.S. Department of Defense Award & Clinical Trial Update
NewsNov 11, 4:07 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsNov 3, 7:05 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
Press releaseOct 31, 6:00 AM ETGlobe Newswire
Immuron Announces Clinical Trial Update
NewsOct 2, 6:38 AM ET
Immuron Says It Is On Track To Exceed FY24 First-Quarter Sales; To Request End Of Phase 2 Meeting With FDA For IMM-124E
Press releaseOct 2, 6:00 AM ETGlobe Newswire
Immuron Letter to Shareholders – Projects Update
Press releaseAug 26, 10:29 PM ETGlobe Newswire
Immuron partners with InvestorHub
NewsMay 21, 8:07 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseJan 15, 6:00 AM ETGlobe Newswire
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
Press releaseJan 14, 6:00 AM ETGlobe Newswire
Immuron Announces Travelan® Clinical Trial Update
Press releaseDec 2, 6:00 AM ETGlobe Newswire
Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th
Press releaseNov 21, 6:33 PM ETGlobe Newswire
Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event
NewsOct 29, 8:07 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsOct 29, 6:12 AM ETAvi Kapoor
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Press releaseOct 16, 6:00 AM ETGlobe Newswire
Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference
Press releaseSep 5, 11:54 AM ETGlobe Newswire
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
Press releaseAug 15, 6:14 PM ETGlobe Newswire
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
Press releaseAug 7, 6:00 AM ETGlobe Newswire
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

12 Health Care Stocks Moving In Friday's Intraday Session

Gold Falls Over 1%; American Outdoor Brands Shares Jump After Q1 Results

Dow Falls Over 100 Points; US Economy Adds 162,000 Jobs In August

Immuron Stock Surges Friday: What's Driving the Action?

Market-Moving News for September 4th

Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket

Why Braze Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Immuron New U.S. Department of Defense Award & Clinical Trial Update

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Monday's Pre-Market Session

Immuron Announces Clinical Trial Update

Immuron Says It Is On Track To Exceed FY24 First-Quarter Sales; To Request End Of Phase 2 Meeting With FDA For IMM-124E

Immuron Letter to Shareholders – Projects Update

Immuron partners with InvestorHub

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Immuron Announces New Research Collaboration targeting Antimicrobial Resistance

Immuron Announces Travelan® Clinical Trial Update

Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket

Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference

Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect